Issues: Vax Specific

Anthrax

Hepatitis B

Hib

HPV

Influenza

Lyme Disease
Meningococcal

MMR    

Polio

Rotavirus

● Smallpox

Tdap/Td

Varicella

Yellow Fever

 

Issues: Misc

Exemptions

Legislation 

New Vax Status

Thimerosal

Independent Vax  Safety Board

 

Vaccine Info

2011 Schedule

ACIP Recs

Components
IOM Reports

● Vax Injury Comp Program
Manufacturer Links

Package Inserts

Reporting AEs

Thimerosal Table

VAERS

VISs

 

Links
 

Search
 

About IVS

Faculty Biographies

Publications

Donations

 

Email IVS

 

Disclaimers & Privacy
 

 

Institute for Vaccine Safety

Johns Hopkins Bloomberg School of Public Health

615 N. Wolfe Street

Room W5041

Baltimore, MD 21205

www.vaccinesafety.edu

 

 

 

Components of
DTaP
IPVHib Vaccine
Excipients Table
Allergens Table
Components Table
 

Indication

 For active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b

Proprietary Name

Pentacel

Manufacturer

sanofi pasteur

Viability

Inactivated

Microorganism

Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis, Hepatitis B virus, Polioviruses type 1, 2, and 3, Haemophilus influenzae type b strain 1482

Ages

6 weeks - 4 years (prior to 5th birthday)

Dose

0.5 mL

Route

Intramuscular

Dose form

Suspension plus powder

Appearance

uniform, cloudy, white to off-white (yellow tinge)

Concentration (per 0.5 mL)

Diphtheria toxoid, 15 Lf U

Tetanus toxoid, 5 Lf U

Detoxified pertussis toxin, 20 mcg

Filamentous hemagglutinin, 20 mcg

Inactivated polioviruses [40 D-antigen units (DU) Type 1 (Mahoney), 8 DU Type 2 (MEF-1), 32 DU Type 3 (Saukett)]

H. influenzae type b, 10 mcg covalently bound to tetanus toxoid, 24 mcg

Preservatives

None

Adjuvant

Aluminum phosphate, 0.33 mg

Excipients

Formaldehyde (residual), ≤5 mcg

Glutaraldhyde (residual), <50 ng

Bovine serum albumin, ≤50 ng

2-phenoxyethanol (not as a preservative), 3.3 mg

Neomycin, <4 pg

Polysorbate 80, 10 ppm

Allergens

Polymyxin B sulfate, <4 pg

Media

       

Bordetella pertussis

Stainer-Scholte modified by casamino acids and dimethyl-beta-cyclodextrin

Corynebacterium diphtheria

Modified Mueller’s growth medium. Detoxified using formaldehyde Purified using serial ammonium sulfate fractionation and diafiltration

Poliovirus Type 1, Type 2, Type 3 

Each grown in separate cultures of MRC-5 cells, a line of normal human diploid cells

Clostridium tetani  

Modified Mueller-Miller casamino acid medium without beef heart infusion. Detoxified using formaldehyde and purified using ammonium sulfate fractionation and diafiltration.

Haemophilus influenzae type b strain 1482  

Grown in a semi-synthetic medium. The tetanus toxoid for conjugation to PRP is prepared by ammonium sulfate purification, and formalin inactivation of the toxin from cultures of Clostridium tetani (Harvard strain) grown in a modified Mueller and Miller medium. The toxoid is filter sterilized prior to the conjugation process.

Packaging

Dose Package containing 5 vials of DTaP-IPV component to be used to reconstitute five single dose vials of lyophilized ActHIB vaccine component

Routine storage

2 to 8° C (36-46° F)

Do Not Freeze

Package Insert date December 2009

updated June 2011

 

This page was last updated on October 03, 2011

© 2011 Institute for Vaccine Safety